1
|
Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.
|
Biochem Pharmacol
|
2006
|
1.91
|
2
|
Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
|
Cancer Res
|
2003
|
1.45
|
3
|
Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
|
Carcinogenesis
|
2008
|
1.27
|
4
|
Antiinflammatory constituents of Celastrus orbiculatus inhibit the NF-kappaB activation and NO production.
|
J Nat Prod
|
2002
|
1.18
|
5
|
Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
|
Cancer Res
|
2010
|
1.17
|
6
|
Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors.
|
Bioorg Med Chem Lett
|
2007
|
1.12
|
7
|
(Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors.
|
J Med Chem
|
2007
|
1.10
|
8
|
An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination.
|
J Biol Chem
|
2010
|
1.03
|
9
|
Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes.
|
J Biol Chem
|
2002
|
1.01
|
10
|
Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
|
J Pharmacol Exp Ther
|
2005
|
0.95
|
11
|
Rational biosynthetic engineering for optimization of geldanamycin analogues.
|
Chembiochem
|
2009
|
0.94
|
12
|
Inactivation of the carbamoyltransferase gene refines post-polyketide synthase modification steps in the biosynthesis of the antitumor agent geldanamycin.
|
J Am Chem Soc
|
2004
|
0.93
|
13
|
Hypoxia-inducible factor-1 inhibitory benzofurans and chalcone-derived diels-alder adducts from Morus species.
|
J Nat Prod
|
2009
|
0.92
|
14
|
Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis.
|
PLoS One
|
2012
|
0.91
|
15
|
Phenanthroquinolizidine alkaloids from the roots of Boehmeria pannosa potently inhibit hypoxia-inducible factor-1 in AGS human gastric cancer cells.
|
J Nat Prod
|
2006
|
0.91
|
16
|
The first total synthesis of moracin O and moracin P, and establishment of the absolute configuration of moracin O.
|
Chem Commun (Camb)
|
2009
|
0.91
|
17
|
Phenolic constituents of Amorpha fruticosa that inhibit NF-kappaB activation and related gene expression.
|
J Nat Prod
|
2008
|
0.89
|
18
|
Cucurbitacin B suppresses the transactivation activity of RelA/p65.
|
J Cell Biochem
|
2011
|
0.89
|
19
|
A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway.
|
Biochem Biophys Res Commun
|
2009
|
0.88
|
20
|
Angiogenic activity of sesamin through the activation of multiple signal pathways.
|
Biochem Biophys Res Commun
|
2009
|
0.87
|
21
|
Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms.
|
Arch Pharm Res
|
2006
|
0.86
|
22
|
A novel dihydroxanthenone, AGI-B4 with inhibition of VEGF-induced endothelial cell growth.
|
J Antibiot (Tokyo)
|
2002
|
0.86
|
23
|
Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthase.
|
Exp Mol Med
|
2012
|
0.86
|
24
|
Mutasynthesis of geldanamycin by the disruption of a gene producing starter unit: generation of structural diversity at the benzoquinone ring.
|
Chembiochem
|
2007
|
0.86
|
25
|
Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression.
|
Int Immunopharmacol
|
2008
|
0.85
|
26
|
Lignans from Saururus chinensis inhibiting the transcription factor NF-kappaB.
|
Phytochemistry
|
2003
|
0.85
|
27
|
Caesaldecan, a cassane diterpenoid from the leaves of Caesalpinia decapetala.
|
Chem Pharm Bull (Tokyo)
|
2005
|
0.85
|
28
|
Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: new insight into the formation of the benzoquinone moiety.
|
Chembiochem
|
2006
|
0.85
|
29
|
Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1.
|
J Nat Prod
|
2007
|
0.85
|
30
|
Diarylheptanoids from Alnus hirsuta inhibit the NF-kB activation and NO and TNF-alpha production.
|
Biol Pharm Bull
|
2007
|
0.84
|
31
|
Furanoligularenone, an eremophilane from Ligularia fischeri, inhibits the LPS-induced production of nitric oxide and prostaglandin E2 in macrophage RAW264.7 cells.
|
Planta Med
|
2002
|
0.83
|
32
|
The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
|
Oncol Rep
|
2010
|
0.83
|
33
|
A diterpenoid acanthoic acid from Acanthopanax koreanum protects against D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
|
Biol Pharm Bull
|
2008
|
0.83
|
34
|
Sauchinone, a lignan from Saururus chinensis, suppresses iNOS expression through the inhibition of transactivation activity of RelA of NF-kappaB.
|
Planta Med
|
2003
|
0.82
|
35
|
Inhibitors of the LPS-induced NF-kappaB activation from Artemisia sylvatica.
|
Phytochemistry
|
2004
|
0.82
|
36
|
Zinc-finger protein 91 plays a key role in LIGHT-induced activation of non-canonical NF-κB pathway.
|
Biochem Biophys Res Commun
|
2010
|
0.82
|
37
|
A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
|
Eur J Pharmacol
|
2008
|
0.82
|
38
|
Hepatoprotective effects of Sedum sarmentosum on D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure.
|
J Pharmacol Sci
|
2010
|
0.82
|
39
|
Tephrosin induces internalization and degradation of EGFR and ErbB2 in HT-29 human colon cancer cells.
|
Cancer Lett
|
2010
|
0.81
|
40
|
Cytotoxic prenylated flavonoids from Morus alba.
|
Fitoterapia
|
2010
|
0.81
|
41
|
4′,6-dihydroxy-4-methoxyisoaurone inhibits the HIF-1α pathway through inhibition of Akt/mTOR/p70S6K/4E-BP1 phosphorylation.
|
J Pharmacol Sci
|
2014
|
0.81
|
42
|
Fungal metabolites, asterric acid derivatives inhibit vascular endothelial growth factor (VEGF)-induced tube formation of HUVECs.
|
J Antibiot (Tokyo)
|
2002
|
0.80
|
43
|
Kaurane-type diterpene glycoside from the stem bark of Acanthopanax trifoliatus.
|
Planta Med
|
2004
|
0.80
|
44
|
Hypoxia-inducible factor-1 and nuclear factor-kappaB inhibitory meroterpene analogues of bakuchiol, a constituent of the seeds of Psoralea corylifolia.
|
Bioorg Med Chem Lett
|
2008
|
0.80
|
45
|
New sesquiterpene dimers from Inula britannica inhibit NF-kappaB activation and NO and TNF-alpha production in LPS-stimulated RAW264.7 cells.
|
Planta Med
|
2006
|
0.80
|
46
|
Two new furanoditerpenes from Saururus chinenesis and their effects on the activation of peroxisome proliferator-activated receptor gamma.
|
J Nat Prod
|
2002
|
0.79
|
47
|
Lupane-triterpene carboxylic acids from the leaves of Acanthopanax trifoliatus.
|
Chem Pharm Bull (Tokyo)
|
2003
|
0.79
|
48
|
In vitro and in vivo antiallergic effect of the fructus of Evodia rutaecarpa and its constituents.
|
Biol Pharm Bull
|
2007
|
0.79
|
49
|
A peroxisome proliferator-activated receptor-gamma agonist and other constituents from Chromolaena odorata.
|
Planta Med
|
2009
|
0.79
|
50
|
Acanthoic acid from Acanthopanax koreanum protects against liver injury induced by tert-butyl hydroperoxide or carbon tetrachloride in vitro and in vivo.
|
Planta Med
|
2004
|
0.79
|
51
|
Lupane-triterpenes from the leaves of Brassaiopsis glomerulata.
|
Arch Pharm Res
|
2003
|
0.78
|
52
|
Four ent-kaurane-type diterpenoids from Croton tonkinensis Gagnep.
|
Chem Pharm Bull (Tokyo)
|
2004
|
0.78
|
53
|
Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264.7 cells by inducing proteasomal degradation of TRAF6.
|
Eur J Pharmacol
|
2010
|
0.78
|
54
|
An isoaurone and other constituents from Trichosanthes kirilowii seeds inhibit hypoxia-inducible factor-1 and nuclear factor-kappaB.
|
J Nat Prod
|
2010
|
0.78
|
55
|
Effect of 5-O-Methylhirsutanonol on nuclear factor-kappaB-dependent production of NO and expression of iNOS in lipopolysaccharide-induced RAW264.7 cells.
|
J Agric Food Chem
|
2007
|
0.78
|
56
|
Quinolone alkaloids from evodiae fructus and their inhibitory effects on monoamine oxidase.
|
Arch Pharm Res
|
2007
|
0.78
|
57
|
Water-soluble polysaccharide from Eleutherococcus senticosus stems attenuates fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
|
Basic Clin Pharmacol Toxicol
|
2004
|
0.78
|
58
|
Pentacyclic triterpenoids from Mallotus apelta.
|
Arch Pharm Res
|
2004
|
0.77
|
59
|
Suppression of RelA/p65 transactivation activity by a lignoid manassantin isolated from Saururus chinensis.
|
Biochem Pharmacol
|
2003
|
0.77
|
60
|
Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo.
|
Arch Pharm Res
|
2008
|
0.77
|
61
|
Triterpenoids and diarylheptanoids from Alnus hirsuta inhibit HIF-1 in AGS cells.
|
Arch Pharm Res
|
2007
|
0.77
|
62
|
Quinolone alkaloids with inhibitory activity against nuclear factor of activated T cells from the fruits of Evodia rutaecarpa.
|
Biol Pharm Bull
|
2004
|
0.77
|
63
|
6-Alkylsalicylic acid analogues inhibit in vitro ATPase activity of heat shock protein 90.
|
Arch Pharm Res
|
2010
|
0.77
|
64
|
Two new phenylpropanoid glycosides from the stem bark of Acanthopanax trifoliatus.
|
Arch Pharm Res
|
2003
|
0.77
|
65
|
Phenolic constituents with inhibitory activity against NFAT transcription from Desmos chinensis.
|
Arch Pharm Res
|
2005
|
0.77
|
66
|
Pharmacophore-based 3D-QSAR of HIF-1 inhibitors.
|
Arch Pharm Res
|
2009
|
0.77
|
67
|
Kaurane diterpenoids from Isodon excisus inhibit LPS-induced NF-kappaB activation and NO production in macrophage RAW264.7 cells.
|
J Nat Prod
|
2007
|
0.76
|
68
|
Fungal metabolites, sorbicillinoid polyketides and their effects on the activation of peroxisome proliferator-activated receptor gamma.
|
J Antibiot (Tokyo)
|
2005
|
0.76
|
69
|
Triterpenoids from Acanthopanax koreanum root and their inhibitory activities on NFAT transcription.
|
Arch Pharm Res
|
2004
|
0.75
|
70
|
Torilin from Torilis japonica, as a new inhibitor of testosterone 5 alpha-reductase.
|
Planta Med
|
2003
|
0.75
|
71
|
Identification of three positive regulators in the geldanamycin PKS gene cluster of Streptomyces hygroscopicus JCM4427.
|
J Microbiol Biotechnol
|
2010
|
0.75
|
72
|
A new 24-nor-lupane-glycoside of Acanthopanax trifoliatus.
|
Arch Pharm Res
|
2003
|
0.75
|
73
|
Inhibitory effect of TNF-alpha and IL-8 secretion by pimarane-type diterpenoids from Acanthopanax koreanum.
|
Chem Pharm Bull (Tokyo)
|
2003
|
0.75
|
74
|
Wilfoside K1N isolated from Cynanchum wilfordii inhibits angiogenesis and tumor cell invasion.
|
Int J Oncol
|
2005
|
0.75
|
75
|
Synthesis of 4-acetylisocoumarin: first total syntheses of AGI-7 and sescandelin.
|
J Org Chem
|
2002
|
0.75
|
76
|
Pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after i.v. bolus multiple administration in rats.
|
Arch Pharm Res
|
2005
|
0.75
|
77
|
ent-Kaurane diterpenoids from croton tonkinensis inhibit LPS-induced NF-kappaB activation and NO production.
|
J Nat Prod
|
2003
|
0.75
|
78
|
A new phenyl glycoside from the aerial parts of Equisetum hyemale.
|
Nat Prod Res
|
2014
|
0.75
|
79
|
Inhibition of NF-IL6 activity by manassantin B, a dilignan isolated from Saururus chinensis, in phorbol myristate acetate-stimulated U937 promonocytic cells.
|
Mol Cells
|
2005
|
0.75
|
80
|
New cytotoxic benzopyrans from the leaves of Mallotus apelta.
|
Arch Pharm Res
|
2005
|
0.75
|
81
|
Inhibitory effects of curcuminoids on passive cutaneous anaphylaxis reaction and scratching behavior in mice.
|
Arch Pharm Res
|
2010
|
0.75
|
82
|
Apoptosis induced by ID6105, a new anthracycline (11-hydroxyaclacinomycin X, Hyrubicin), and its anti-tumor effects on experimental tumor models.
|
Cancer Chemother Pharmacol
|
2006
|
0.75
|
83
|
Yangonin blocks tumor necrosis factor-α-induced nuclear factor-κB-dependent transcription by inhibiting the transactivation potential of the RelA/p65 subunit.
|
J Pharmacol Sci
|
2012
|
0.75
|
84
|
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin).
|
Cancer Chemother Pharmacol
|
2005
|
0.75
|
85
|
Inhibitory effect of kaurane type diterpenoids from Acanthopanax koreanum on TNF-alpha secretion from trypsin-stimulated HMC-1 cells.
|
Arch Pharm Res
|
2003
|
0.75
|